Recombinant FGF7 is Food and Drug Administration approved for the ... of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily ...

In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April 2024, the number of shares that each warrant entitles ...

PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, noted that its Founded Entity, ...

NEW YORK, NY, USA I5, 2025 I Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® ...

This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

A group of state lawmakers are again trying to create a state panel that would review prescription drug prices. Sun-Times file photo Share For more than four years, a bill to establish a ...

designed Lily’s COVID antibody using AI, along with a large library of mouse models. But it wouldn’t be considered “pure play” AI.) Nonetheless, the first pure play AI drug discovery ...

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibody discovery and development.